약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 1.

Demographic characteristics of PPSV23 recipients whose vaccination records were reported to the Korea Immunization Registry Information System, 2013-2020

Characteristics N %
Total 6,705,624 100.0
Gender
Male 2,947,653 44.0
Female 3,757,971 56.0
Age at the time of first PPSV23 vaccination (mean 70.89, SD 6.39)
65-69 3,489,954 52.0
70-74 1,432,579 21.4
75-79 1,018,605 15.2
≥80 764,486 11.4
Year of first PPSV23 vaccination
2013 2,488,053 37.1
2014 944,355 14.1
2015 673,530 10.0
2016 441,240 6.6
2017 522,166 7.8
2018 274,853 4.1
2019 560,603 8.4
2020 800,824 11.9
Region of first PPSV23 vaccination institution
Seoul 1,138,198 17.0
Busan 532,200 7.9
Daegu 280,372 4.2
Incheon 311,588 4.6
Gwangju 160,408 2.4
Daejeon 161,118 2.4
Ulsan 115,881 1.7
Sejong 22,878 0.3
Gyeonggi 1,314,913 19.6
Gangwon 273,123 4.1
Chungbuk 254,821 3.8
Chungnam 353,025 5.3
Jeonbuk 345,455 5.2
Jeonnam 392,891 5.9
Gyeongbuk 484,579 7.2
Gyeongnam 474,101 7.1
Jeju 90,073 1.3

PPSV23, 23-valent pneumococcal polysaccharide vaccine; SD, standard deviation.

Yakhak Hoeji 2023;67:277-84 https://doi.org/10.17480/psk.2023.67.4.277
© 2023 Yakhak Hoeji